CompletedPhase 2/3

Evaluation of Dentin Hypersensitivity Using Glass Ionomer Cements

20 participantsStarted 2014-04-02

Plain-language summary

The aim of this randomized, double-blind, split-mouth clinical trial is to evaluate and compare the desensitizing efficacies of the resin-modified glass ionomer cement ClinproTM XT (3M ESPE, Minnesota, USA) and the conventional glass ionomer cement Vidrion R (SS White, Gloucester, UK) at 2-year follow-up.

Who can participate

Age range28 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male and female subjects between 18 and 70 years old * At least 2 teeth with dentin hypersensitivity in two different hemiarchs * Dental elements with hypersensitivity without any pulp alteration * People who are not taking any medication and women who are not pregnant * Patients without eating disorders or very acidic diets. Exclusion Criteria: * Teeth with hypersensitivity that presented extensive or unsatisfactory restorations, fractures, periodontal alterations, caries lesions, orthodontic brackets, endodontic treatments, pulp alterations. * Subjects who received any desensitizing therapy during the last 3 months * Subjects being under analgesics/anti-inflammatory drugs at the time of the study * Teeth with hypersensitivity and non-carious cervical lesions

What they're measuring

Pain Scores as measured by the Visual Analog Scale (VAS)

Timeframe: Change from Baseline in Pain Scores at 20 minutes; at 7, 15, 21, 30 days; and after 3, 6, 12, 24 months.

Trial details

NCT IDNCT02378129

SponsorFederal University of Pelotas

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-04-01

View on ClinicalTrials.gov More Dentin Hypersensitivity trials